Driven by rising consumer interest in “natural” health interventions, the nutraceutical market has exploded in recent years.
But behind the buzzwords lies a stark reality: many products remain under-researched … and rigorous clinical trials are still the exception rather than the rule.
As the industry matures, the current state of clinical trials in nutraceuticals reflects both significant progress and stubborn structural challenges.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.
Subscribe now Already a subscriber? Sign in here.